These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol. Tummon IS, Ali A, Pepping ME, Radwanska E, Binor Z, Dmowski WP. Fertil Steril; 1988 May; 49(5):792-6. PubMed ID: 3129312 [Abstract] [Full Text] [Related]
7. A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group. Dawood MY, Spellacy WN, Dmowski WP, Gambrell RD, Greenblatt RB, Girard Y, Lemay A, Mishell DR, Nagamani M, Pepperell RJ. Prog Clin Biol Res; 1990 May; 323():253-67. PubMed ID: 2106142 [No Abstract] [Full Text] [Related]
8. Sex steroid levels during treatment of endometriosis. Hirschowitz JS, Soler NG, Wortsman J. Obstet Gynecol; 1979 Oct; 54(4):448-50. PubMed ID: 492624 [Abstract] [Full Text] [Related]
10. Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis. Rannevik G. Postgrad Med J; 1979 Oct; 55 Suppl 5():14-20. PubMed ID: 537948 [Abstract] [Full Text] [Related]
16. The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis. Maouris P, Dowsett M, Rose G, Edmonds DK, Rothwell C, Robertson WR. Clin Endocrinol (Oxf); 1990 Oct; 33(4):539-46. PubMed ID: 2146047 [Abstract] [Full Text] [Related]
20. LRF and TRF test during long-term danazol treatment: increase of the LH and FSH responses but decrease of the prolactin and TSH responses. Leppäluoto J, Rönnberg L, Ylöstalo P. Acta Endocrinol (Copenh); 1983 Sep; 104(1):1-5. PubMed ID: 6414205 [Abstract] [Full Text] [Related] Page: [Next] [New Search]